Stocks are lower as a weaker U.S. dollar help lift commodity prices and Johnson & Johnson’s third-quarter sales figures disappointed investors

Stocks fell on Tuesday after disappointing quarterly sales figures from economic bellwether Johnson & Johnson (NYSE: JNJ) sparked worries about consumer spending, offsetting a lift from higher commodity prices.

The Nasdaq gave up its initial gains at the open.

The Dow Jones industrial average was down 53.66 points, or 0.54 percent, at 9,832.14. The Standard & Poor’s 500 Index was down 7.19 points, or 0.67 percent, at 1,069.00. The Nasdaq Composite Index was down 5.16 points, or 0.24 percent, at 2,133.98.

Yesterday’s Top Performing Small Cap Stock:

GWS Technologies, Inc, (OTC BB: GWSC) was a eXpressIR top performer yesterday closing up over 8% on trading volume of 19,747 shares.

GWS stands for GreenWindSolar. GWSC is a renewable energy technology company developing and marketing solar and wind-powered renewable energy products and solutions. Our products and solutions are part of the new micro-generation movement that is transforming the way businesses and consumers provide for their energy needs. The company was founded in 2005 and is headquartered in Scottsdale, Arizona.

Today’s eXpressIR Hot Stock to Watch:

Viper Networks, Inc. (Pink Sheets: VPER)

Viper Networks, Inc., a telecommunication network operations and technical management company, announces that it has secured an institutional funding commitment with a private equity firm based in Riyadh, Saudi Arabia for $10,0000,000 (U.S. dollars) with an option for an additional $5,000,000.

This non-dilutive, debt financing is a direct obligation of the company’s previously announced India Joint Venture with Cirilium India Pvt. Ltd. and not Viper Networks, Inc. Upon repayment, the investor will retain a minority interest in the India Joint Venture. The financing will be funded in $2,500,000 traunches and will be used for equipment, expanding routes and working capital.

eXpressIR News Highlight:

Cellceutix Corporation (OTCBB: CTIX) today announced that it presented a poster and its Chief Scientific Officer, Dr. Krishna Menon, was one of only four individuals selected to participate in an expert panel discussion of the abstract at the American Association for Cancer Research (AACR) meeting “Frontiers in Basic Cancer Research” in Boston, MA on October 10, 2009. The Company’s poster describes in vitro and in vivo research on its lead compound, Kevetrin(TM), which is being developed for drug resistant cancers.

The three day AACR meeting featured presentations on the latest advances in basic cancer research from around the world. The AACR issued a press release on October 10, 2009 which featured the abstract submitted by Cellceutix http://www.aacr.org/home/public–media/aacr-press-releases.aspx?d=1571